Novartis AG
THE USE OF AN MGLUR5 ANTAGONIST FOR TREATING OPIOID ANALGESIC TOLERANCE
Last updated:
Abstract:
The invention relates to the use of a mGluR5 antagonist for the treatment of opioid analgesic tolerance associated with chronic opioid use in chronic pain.
Status:
Application
Type:
Utility
Filling date:
28 Jan 2020
Issue date:
9 Jun 2022